Xueyi Wu

790 total citations
36 papers, 546 citations indexed

About

Xueyi Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xueyi Wu has authored 36 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xueyi Wu's work include Blood Pressure and Hypertension Studies (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Phytochemicals and Antioxidant Activities (3 papers). Xueyi Wu is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Phytochemicals and Antioxidant Activities (3 papers). Xueyi Wu collaborates with scholars based in China, United States and Egypt. Xueyi Wu's co-authors include Guangliang Shan, Xuan Zhang, Yufeng Yin, Tao Shen, Hong‐Xiang Lou, Dong‐Mei Ren, Xiao‐Ning Wang, Jie Yu, Shenghan Zhou and Wenbing Chang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Food Chemistry.

In The Last Decade

Xueyi Wu

31 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueyi Wu China 12 119 100 73 63 60 36 546
Manuela Stoicescu Romania 13 150 1.3× 99 1.0× 46 0.6× 47 0.7× 32 0.5× 36 585
Pradeep Kumar Dabla India 11 143 1.2× 110 1.1× 149 2.0× 35 0.6× 42 0.7× 54 768
Xiuming Wang China 13 90 0.8× 42 0.4× 62 0.8× 33 0.5× 28 0.5× 29 662
Prakash B Desai India 8 138 1.2× 27 0.3× 105 1.4× 42 0.7× 37 0.6× 9 740
Jae Ho Park South Korea 15 160 1.3× 68 0.7× 130 1.8× 60 1.0× 62 1.0× 52 723
Yunfeng Xiao China 15 256 2.2× 120 1.2× 154 2.1× 15 0.2× 61 1.0× 45 822
Faranak Kazerouni Iran 16 208 1.7× 65 0.7× 105 1.4× 17 0.3× 47 0.8× 55 674
Alexandra Crăciun Romania 18 182 1.5× 54 0.5× 68 0.9× 78 1.2× 30 0.5× 71 859
Shivaraj Gowda India 7 131 1.1× 27 0.3× 111 1.5× 22 0.3× 29 0.5× 11 686
Marius Rus Romania 15 107 0.9× 148 1.5× 113 1.5× 12 0.2× 29 0.5× 37 657

Countries citing papers authored by Xueyi Wu

Since Specialization
Citations

This map shows the geographic impact of Xueyi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyi Wu more than expected).

Fields of papers citing papers by Xueyi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyi Wu. The network helps show where Xueyi Wu may publish in the future.

Co-authorship network of co-authors of Xueyi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyi Wu. A scholar is included among the top collaborators of Xueyi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyi Wu. Xueyi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Dong, et al.. (2025). A brain-targeted and ROS-responsive natural polysaccharide nanogel for enhancing antidepressant therapy. Chemical Engineering Journal. 507. 160719–160719. 1 indexed citations
2.
Liu, Bingbing, et al.. (2025). Knowledge, Attitudes, and Practices of Chronic Type 2 Diabetes Patients in China Toward Continuous Glucose Monitoring: An Online Questionnaire Survey. Diabetes Metabolic Syndrome and Obesity. Volume 18. 11–22. 1 indexed citations
3.
Liu, Bingbing, et al.. (2025). Knowledge, attitude and practice toward liraglutide and semaglutide among endocrinology medical staff. Scientific Reports. 15(1). 11533–11533.
5.
Wu, Xueyi, et al.. (2024). Energy Metabolism Enhance Perylenequinone Biosynthesis in Shiraia sp. Slf14 through Promoting Mitochondrial ROS Accumulation. International Journal of Molecular Sciences. 25(18). 10113–10113.
6.
Fei, Xiang, et al.. (2024). Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review. Kidney & Blood Pressure Research. 49(1). 831–838.
7.
Li, Ruicheng, et al.. (2024). The causal relationship between gut microbiota and immune skin diseases: A bidirectional Mendelian randomization. PLoS ONE. 19(3). e0298443–e0298443. 8 indexed citations
8.
Li, Yunfeng, et al.. (2024). Lightweight full-convolutional siamese tracker. Knowledge-Based Systems. 286. 111439–111439. 7 indexed citations
9.
Wang, Bo, et al.. (2024). RGB-Sonar Tracking Benchmark and Spatial Cross-Attention Transformer Tracker. IEEE Transactions on Circuits and Systems for Video Technology. 35(3). 2260–2275. 3 indexed citations
10.
Liu, Ruihong, Han‐Zhong Zhang, Xueyi Wu, et al.. (2024). The impact of telecom industry employees’ stress perception on job burnout: moderated mediation model. BMC Public Health. 24(1). 1623–1623. 4 indexed citations
11.
Wu, Xueyi, et al.. (2024). Cimicifuga heracleifolia kom. Attenuates ulcerative colitis through the PI3K/AKT/NF-κB signaling pathway. Journal of Ethnopharmacology. 337(Pt 3). 118892–118892. 2 indexed citations
12.
Zhang, Yu, Ming‐Hao Liu, Mo Zhang, et al.. (2023). Different clinical characteristics and outcomes of hypertrophic cardiomyopathy with and without hypertension: seeking the truth. Journal of Geriatric Cardiology. 20(2). 109–120. 2 indexed citations
13.
Zhou, Changyu, Xueyi Wu, Daodong Pan, et al.. (2023). TMT-labeled quantitative proteomic reveals the mechanism of proteolysis and taste improvement of dry-cured bacon with Staphylococcus co-inoculation. Food Chemistry. 436. 137711–137711. 28 indexed citations
14.
Zhao, Kui, Xueyi Wu, Hua Hou, et al.. (2023). Phyllostachys nigra (Lodd. ex Lindl.) derived polysaccharide with enhanced glycolipid metabolism regulation and mice gut microbiome. International Journal of Biological Macromolecules. 257(Pt 1). 128588–128588. 47 indexed citations
15.
Wu, Xueyi, Xuemei Chen, Mingxing Zhou, et al.. (2019). Artocarmitin B enhances intracellular antioxidant capacity via activation of Nrf2 signaling pathway in human lung epithelial cells. Chemico-Biological Interactions. 310. 108741–108741. 5 indexed citations
16.
Wu, Xueyi, et al.. (2019). SIRT6 abrogation promotes adrenocortical carcinoma through activation of NF-κB signaling. Molecular and Cellular Biochemistry. 458(1-2). 1–10. 9 indexed citations
17.
Qin, Fang, Kai Liu, Ce Zhang, et al.. (2019). Steroid metabolism gene variants and their genotype-phenotype correlations in Chinese early-onset hypertension patients. Hypertension Research. 42(10). 1536–1543. 2 indexed citations
18.
Li, Guohui, Yanru Li, Xueyi Wu, et al.. (2018). Lignan and flavonoid support the prevention of cinnamon against oxidative stress related diseases. Phytomedicine. 53. 143–153. 35 indexed citations
19.
Li, Yi, Rongxiu Zhu, Jiaozhen Zhang, et al.. (2018). Clerodane diterpenoids from the Chinese liverwort Jamesoniella autumnalis and their anti-inflammatory activity. Phytochemistry. 154. 85–93. 19 indexed citations
20.
Liu, Kai, Fang Qin, Yang Zhang, et al.. (2017). Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients. Journal of Hypertension. 36(3). 502–509. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026